The genomic and seroprevalence of human bocavirus in healthy Chinese plasma donors and plasma derivatives

Transfusion

Volumn 55, Issue 1, 2015, Pages 154-163

  Li, Hongxue ^a   He, Miao ^a   Zeng, Peibin ^a   Gao, Zhan ^a   Bian, Guohui ^a   Yang, Chunhui ^a   Li, Wuping ^a,b  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b INSTITUTE OF PATHOGEN BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; STRUCTURAL PROTEIN; VIRUS DNA; BLOOD CLOTTING FACTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ADULT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; BOCAVIRUS INFECTION; DNA SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOMICS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYLOGENY; PLASMAPHERESIS; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; SEQUENCE ANALYSIS; SEROEPIDEMIOLOGY; SEROPREVALENCE; VIRAL CONTAMINATION; VIRUS LOAD; ASIAN CONTINENTAL ANCESTRY GROUP; ASYMPTOMATIC DISEASE; BLOOD; BLOOD SAFETY; CHINA; CLASSIFICATION; GENETICS; HUMAN BOCAVIRUS; ISOLATION AND PURIFICATION; PARVOVIRIDAE INFECTIONS; PLASMA; SENSITIVITY AND SPECIFICITY; VIREMIA; VIROLOGY; VIRUS GENOME;

ADULT; ANTIBODIES, VIRAL; ASIAN CONTINENTAL ANCESTRY GROUP; ASYMPTOMATIC DISEASES; BLOOD COAGULATION FACTORS; BLOOD DONORS; BLOOD SAFETY; CHINA; DNA, VIRAL; GENOME, VIRAL; GENOTYPE; HUMAN BOCAVIRUS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULINS, INTRAVENOUS; PARVOVIRIDAE INFECTIONS; PHYLOGENY; PLASMA; PLASMAPHERESIS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEROEPIDEMIOLOGIC STUDIES; VIREMIA;

EID: 84920873528     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12785     Document Type: Article

References (37)

1. Allander T, Eriksson M, Bjerkner A, et al. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci U S A 2005; 102: 12891-12896.
2. Arthur JL, Higgins GD, Davidson GP, et al. A novel bocavirus associated with acute gastroenteritis in Australian children. Plos Pathog 2009; 5: e1000391.
3. Kapoor A, Slikas E, Simmonds P, et al. A newly identified bocavirus species in human stool. J Infect Dis 2009; 199: 196-200.
4. Kapoor A, Simmonds P, Slikas E, et al. Human bocaviruses are highly diverse, dispersed, recombination prone, and prevalent in enteric infections. J Infect Dis 2010; 201: 1633-1643.
5. Allander T, Jartti T, Gupta S, et al. Human bocavirus and acute wheezing in children. Clin Infect Dis 2007; 44: 904-910.
6. Fry AM, Lu X, Chittaganpitch M, et al. Human bocavirus: a novel parvovirus epidemiologically associated with pneumonia requiring hospitalization in Thailand. J Infect Dis 2007; 195: 1038-1045.
7. Schildgen O, Muller A, Allander T, et al. Human bocavirus: passenger or pathogen in acute respiratory tract infections? Clin Microbiol Rev 2008; 21: 291-304.
8. Brieu N, Gay B, Segondy M, et al. Electron microscopy observation of human bocavirus (HBoV) in nasopharyngeal samples from HBoV-infected children. J Clin Microbiol 2007; 45: 3419-3420.
9. Burns K, Parrish CR,. Parvo viridae. In:, Fields BN, Knipe DM, Howley PM, editors. Fields' virology. 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2007. p. 2437-2466.
10. Allander T,. Human bocavirus. J Clin Virol 2008; 41: 29-33.
11. Han TH, Kim CH, Park SH, et al. Detection of human bocavirus-2 in children with acute gastroenteritis in South Korea. Arch Virol 2009; 154: 1923-1927.
12. Qiu J, Guo L, Wang Y, et al. Differential seroprevalence of human bocavirus species 1-4 in Beijing, China. PloS ONE 2012; 7: e39644.
13. Karalar L, Lindner J, Schimanski S, et al. Prevalence and clinical aspects of human bocavirus infection in children. Clin Microbiol Infect 2010; 16: 633-639.
14. Bonvicini F, Manaresi E, Gentilomi GA, et al. Evidence of human bocavirus viremia in healthy blood donors. Diagn Microbiol Infect Dis 2011; 71: 460-462.
15. Zhang W, Ke L, Changqing L, et al. Parvovirus B19V DNA contamination in Chinese plasma and plasma derivatives. J Transl Med 2012; 10: 194.
16. Thompson JD, Gibson TJ, Plewniak F, et al. The CLUSTAL-X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997; 25: 4876-4882.
17. Tamura K, Dudley J, Nei M, et al. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24: 1596-1599.
18. Jartti T, Hedman K, Jartti L, et al. Human bocavirus-the first 5 years. Rev Med Virol 2012; 22: 46-64.
19. Deng X, Yan Z, Luo Y, et al. In vitro modeling of human bocavirus 1 infection of polarized primary human airway epithelia. J Virol 2013; 87: 4097-4102.
20. Fryer JF, Delwart E, Hecht FM, et al. Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals. Transfusion 2007; 47: 1054-1061.
21. Neske F, Blessing K, Tollmann F, et al. Real-time PCR for diagnosis of human bocavirus infections and phylogenetic analysis. J Clin Microbiol 2007; 45: 2116-2122.
22. Tozer SJ, Lambert SB, Whiley DM, et al. Detection of human bocavirus in respiratory, fecal, and blood samples by real-time PCR. J Med Virol 2009; 81: 488-493.
23. Christensen A, Nordbo SA, Krokstad S, et al. Human bocavirus in children: mono-detection, high viral load and viraemia are associated with respiratory tract infection. J Clin Virol 2010; 49: 158-162.
24. Azzi A, Ciappi S, Zakvrzewska K, et al. Human parvovirus B19 infection in hemophiliacs first infused with two high-purity, virally attenuated factor VIII concentrates. Am J Hematol 1992; 39: 228-230.
25. Santagostino E, Mannucci PM, Gringeri A, et al. Eliminating parvovirus B19 from blood products. Lancet 1994; 343: 798.
26. Laurian Y, Dussaix E, Parquet A, et al. Transmission of human parvovirus B19 by plasma derived factor VIII concentrates. Nouv Rev Fr Hematol 1994; 36: 449-453.
27. Rollag H, Patou G, Pattison JR, et al. Prevalence of antibodies against parvovirus B19 in Norwegians with congenital coagulation factor defects treated with plasma products from small donor pools. Scand J Infect Dis 1991; 23: 675-679.
28. Kleinman SH, Glynn SA, Lee TH, et al. A linked donor-recipient study to evaluate parvovirus B19 transmission by blood component transfusion. Blood 2009; 114: 3677-3683.
29. Satake M, Hoshi Y, Taira R, et al. Symptomatic parvovirus B19 infection caused by blood component transfusion. Transfusion 2011; 51: 1887-1895.
30. Hourfar MK, Mayr-Wohlfart U, Themann A, et al. Recipients potentially infected with parvovirus B19 by red blood cell products. Transfusion 2011; 51: 129-136.
31. Brown KE, Young NS, Alving BM, et al. Parvovirus B19: implications for transfusion medicine. Summary of a workshop. Transfusion 2001; 41: 130-135.
32. Tabor E, Yu MY, Hewlett I, et al. Summary of a workshop on the implementation of NAT to screen donors of blood and plasma for viruses. Transfusion 2000; 40: 1273-1275.
33. Delwart E,. Human parvovirus 4 in the blood supply and transmission by pooled plasma-derived clotting factors: does it matter? Transfusion 2012; 52: 1398-1403.
34. Sharp CP, Lail A, Donfield S, et al. Virologic and clinical features of primary infection with human parvovirus 4 in subjects with hemophilia: frequent transmission by virally inactivated clotting factor concentrates. Transfusion 2012; 52: 1482-1489.
35. Modrow S, Wenzel JJ, Schimanski S, et al. Prevalence of nucleic acid sequences specific for human parvoviruses, hepatitis A and hepatitis E viruses in coagulation factor concentrates. Vox Sang 2011; 100: 351-358.
36. Kantola K, Hedman L, Arthur J, et al. Seroepidemiology of human bocaviruses 1-4. J Infect Dis 2011; 204: 1403-1412.
37. Brebion A, Vanlieferinghen P, Dechelotte P, et al. Fatal sub-acute myocarditis associated with human bocavirus 2 in a 13-month-old child. J Clin Microbiol 2013; 52: 1006-1008.